Skip to main content

Aratana Therapeutics reports loss

Aratana Therapeutics Inc. (Nasdaq: PETX) reported a loss for the fourth quarter sending the stock price down 63 cents to close at $3.80.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.